• ArcelorMittal: JP Morgan advises its customers to buy the stock. The target price remains unchanged at EUR 29.50.
  • Bausch Health: RBC Capital has kept its Outperform rating and lowered its one year price target to USD 41, from USD 42.
  • CVS Health: Jefferies moves Price Target to $95 From $90, maintains Buy rating
  • Esperion Therapeutics: BTIG Research adjusts PT to $71 From $90, keeps Buy rating
  • HSBC Holdings: Goldman Sachs maintains its Buy rating on the stock. The target price continues to be set at GBp 555.
  • Hugo Boss: Jefferies remains in the hold category with its target price raised from EUR 32 to EUR 38.
  • ING Groep: UBS is Buy. The target price is still at EUR 11.50.
  • Logitech: UBS remains neutral with a price target raised to CHF 110 from CHF 108.
  • Lowe's: Wells Fargo lifts PT to $225 From $210, keeps Overweight rating
  • National Grid: Berenberg upgrades from Hold to Buy with a target of GBp 1100.
  • Pearson: Exane BNP Paribas upgrades from neutral to outperform with a target of GBP 950.
  • Reckitt Benckiser: Jefferies remains Hold with a price target raised to GBp 6050 from GBp 5950. 
  • Thomson Reuters: RBC Capital remains Outperform and raised its PT to USD 104, from USD 100
  • UBS Group: Goldman Sachs maintains his neutral opinion on the stock. The PT is being increased from CHF 16.20 to CHF 17.60.
  • AB Volvo: Goldman Sachs keeps its Buy rating. The price target is reviewed upwards from SEK 266 to SEK 274.
  • Zalando: Credit Suisse stays Neutral on the stock. The price is set at 100 versus 98 EUR.